Turn this list into pipeline.
Biotech Companies in Nottingham: 35 Active Firms (2026)
Biotech companies in Nottingham develop biological therapies, diagnostics and research tools within the city’s life-sciences cluster.
Buying centres tend to sit with R&D, translational medicine and laboratory operations rather than general procurement. In Nottingham, the relevant buyers are usually pharmaceutical research teams, NHS-linked clinical or diagnostics groups, universities and contract research customers seeking assays, biological materials, target validation or specialist lab capacity. Engagements are often scoped as research collaborations, fee-for-service laboratory work, licensing discussions or milestone-based development programmes, with sales cycles shaped by scientific validation and evidence packs rather than short transactional buying.
Read more
Nottingham has 35 actively trading biotech companies, making it a compact city cohort rather than a broad regional cluster. Reported employment across the cohort is 236 people, and 34 of 34 firms reporting headcount means the employment footprint is unusually visible for a small private-company set. The revenue distribution also looks narrow: one company reports turnover above £5M, while the rest sit below that threshold. Formation has not stopped, with 8 companies incorporated since 2022, but the overall picture is still mostly small specialist businesses rather than a dense layer of revenue-scale biopharmaceutical employers.
Biopharmaceutical activity is governed less by a Nottingham-specific rulebook than by UK life-sciences requirements. Where work moves towards human studies or marketed medicines, the MHRA sets standards, reviews clinical trial applications, assesses marketing authorisations and oversees pharmacovigilance after approval. Trials must also follow Good Clinical Practice, ethics review and informed-consent requirements. Market access adds another layer, because approved medicines may face health technology assessment before routine NHS use. ABPI and the BioIndustry Association provide sector representation, but compliance burden tends to fall on each developer and service provider.
Commercial prospects appear uneven. Nottingham’s cohort looks weighted towards specialist discovery, diagnostics support and research-services models, where progress depends on repeat technical proof, partner credibility and access to clinical or academic collaborators. Scale-up scarcity tends to make the local market sensitive to individual contract wins, licensing events and grant-backed programmes. Regulatory scrutiny is unlikely to ease for firms touching clinical development, so documentation quality and trial readiness will matter alongside science. Consolidation may remain selective, with acquirers more interested in validated platforms and hard-to-replicate laboratory capability than general capacity.
35
Active firms
2026
1
Above £5M
turnover threshold
8
Incorporated since 2022
recent formations
Key facts
About 2% of the trading cohort reports turnover above £5M (1 of 35 firms) — the rest sits below that revenue band.
22% of the cohort was incorporated since 2022 (8 firms), so a sizeable share is in its first few filing cycles.
The MHRA approves clinical trial applications, assesses marketing authorisations or drug licences, and monitors safety after authorisation through pharmacovigilance.
Clinical trials must follow Good Clinical Practice, ethics review and informed-consent requirements.
Approved medicines may also be reviewed by NICE before routine NHS use, extending the evidence burden into market access.
The UK life-sciences industry generated £146.9 billion in turnover in 2023/2024, with biopharmaceutical companies accounting for £98.9 billion.
UK biotech raised £3.5 billion in equity investment in 2024, a 94% increase on the previous year, with financing concentrated in a small number of large rounds, mainly from US investors.
Top Nottingham Biotech companies
Phenotypeca Limited
Trajectory
3y · 2023–NowFinancial sub-scores
Computed from 3 filingsDevelops engineered microbial production strains for recombinant protein manufacturing. Provides strain optimisation, custom strain development and process support, and licenses strains for…
Serves biotech and pharmaceutical companies developing or manufacturing recombinant proteins, including biosimilar, biologic therapeutic, vaccine, peptide, skincare and consumer health product teams.
Financial Health
StrongStrong · Growing, Hiring · 11% CAGR over 2y
Location
Frontier Space Technologies Ltd
Trajectory
4y · 2022–NowFinancial sub-scores
Computed from 4 filingsDevelops and operates microgravity research platforms for biotechnology and pharmaceutical experiments in space, including miniaturised laboratories and bioreactors for protein crystallisation, cell…
Serves pharmaceutical and biotechnology R&D teams, life sciences researchers and drug developers seeking microgravity-based experiments for protein crystallisation, cell culture, antibodies and…
Financial Health
WeakWeak
Location
Excellerate Bioscience Limited
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsProvides contract research services in molecular and cellular pharmacology for drug discovery. Conducts target identification and validation, assay development, compound screening,…
Serves B2B pharmaceutical and biotechnology companies, drug discovery teams and research organisations developing therapeutics from target validation through pre-clinical candidate stages.
Financial Health
StrongStrong · Growing, Hiring · 27% CAGR over 4y
Location
CAMBRIDGE CLINICAL LABORATORIES LTD
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsProvides clinical laboratory testing services including molecular diagnostics, oncology and virology assays, next‑generation sequencing, pharmacogenetic and patient profiling tests. Processes samples…
Serves NHS organisations, private healthcare providers, clinicians and other healthcare professionals, as well as private customers seeking personalised healthcare testing and diagnostic support.
Financial Health
DistressedDistressed · -5% CAGR over 4y
Location
Develops and manufactures vaccines and diagnostic products for animal and human health. Conducts pharmaceutical research and development and provides contract development and manufacturing (CDMO)…
Serves veterinary and livestock sectors, healthcare organisations, and pharmaceutical/biotech companies in animal and human health markets.
Financial Health
Insufficient historyInsufficient history
Location
Sourcebio
Provides laboratory services including healthcare diagnostics and genomics. Offers DNA sequencing, genomic analysis, and related testing services to support clinical diagnostics, research, and…
Location
ADVANCED MOLECULAR DIAGNOSTICS LTD
Trajectory
5y · 2020–NowFinancial sub-scores
Computed from 5 filingsManufactures molecular diagnostic instruments, PCR kits and assays for detecting genetic mutations, respiratory, infectious and sexually transmitted diseases, and foodborne pathogens. Also supplies…
Sells to B2B laboratory and diagnostics buyers, including clinical and research labs, healthcare testing providers, veterinary users, and food safety testing organisations needing molecular assays,…
Financial Health
HealthyHealthy · Hiring · 19% CAGR over 4y
Location
Trajectory
3y · 2023–NowFinancial sub-scores
Computed from 3 filingsDevelops wearable magnetoencephalography (MEG) brain imaging systems using optically pumped magnetometer sensors. Provides integrated helmets, magnetic shielding environments and system software to…
Serves neuroscience and clinical research organisations, including university MEG groups, hospitals and labs studying brain function, mental health, epilepsy, Alzheimer’s and traumatic brain injury.
Financial Health
StrongStrong · Hiring · 60% CAGR over 2y
Location
Biomedha Limited
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsFinancial Health
StrongStrong · Hiring · 19% CAGR over 4y
Location
RESEARCH FORCE LTD
Trajectory
2y · 2024–NowFinancial sub-scores
Computed from 2 filingsProvides contract research, development and manufacturing services for the pharmaceutical, materials science and fine chemicals sectors, including synthetic chemistry, route scouting, process and…
Serves B2B customers in pharmaceuticals, materials science and fine chemicals, including teams taking chemistry programmes from early-stage research through GMP and commercial manufacturing.
Financial Health
StrongStrong
Location
Embody Biosignals Limited
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsFinancial Health
DistressedDistressed · 0% CAGR over 4y
Location
WILLOWFORT LTD
Trajectory
5y · 2020–NowFinancial sub-scores
Computed from 5 filingsFinancial Health
DistressedDistressed
Location
Neurotherapeutics Ltd
Trajectory
5y · 2022–NowFinancial sub-scores
Computed from 5 filingsDevelops a wearable wrist device that delivers median nerve stimulation to help people with Tourette’s manage tics. The system provides on‑demand, non‑invasive stimulation controlled by the user,…
Sells direct to consumers living with Tourette syndrome in the UK (excluding Northern Ireland), including people seeking self-managed options for tic control and those dissatisfied with medication or…
Financial Health
StrongStrong · Growing, Hiring · 82% CAGR over 4y
Location
DAW MRL CONSULTANCY LIMITED,
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsFinancial Health
WeakWeak · -68% CAGR over 4y
Location
Dargle Holdings Ltd
Trajectory
4y · 2021–NowFinancial sub-scores
Computed from 4 filingsFinancial Health
HealthyHealthy · 0% CAGR over 3y
Location
Z7 BIOTECH LTD
Trajectory
4y · 2022–NowFinancial sub-scores
Computed from 4 filingsFinancial Health
StrongStrong
Location
Dargle Therapeutics Ltd
Trajectory
3y · 2023–NowFinancial sub-scores
Computed from 3 filingsFinancial Health
HealthyHealthy · 0% CAGR over 2y
Location
Pathfinder Bio Ltd
Trajectory
2y · 2024–NowFinancial sub-scores
Computed from 2 filingsFinancial Health
HealthyHealthy · 0% CAGR over 1y
Location
Cellomatics Biosciences Limited
Trajectory
5y · 2020–NowFinancial sub-scores
Computed from 5 filingsProvides contract pre-clinical research services for drug discovery, including bespoke bioassay development, cell-based and molecular assays, immunoassays, flow cytometry and cell culture. Conducts…
Serves pharmaceutical, biotech and life sciences research teams needing pre-clinical R&D support across oncology, immunology, respiratory, inflammation and translational disease models.
Financial Health
StableStable · Hiring · 19% CAGR over 4y
Location
Nuvision Biotherapies Limited
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsDevelops and manufactures amniotic membrane–based biotherapies for ocular surface disease and eye injuries. Products include Omnigen wound dressing and graft material and OmniLenz bespoke contact…
Serves ophthalmologists, optometrists, eye-care clinics and hospitals treating patients with ocular surface disease or injury, with supporting information for patients considering clinician-led care.
Financial Health
StrongStrong · Growing, Hiring · 18% CAGR over 4y
Location
NANOFCM CO., LTD
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsDevelops and manufactures nano‑flow cytometry instruments, including nanoanalyzers and single‑molecule analyzers, along with reagents and consumables for detecting and characterising…
Serves life science researchers and laboratory teams in universities, biotech and pharmaceutical companies, vaccine developers, nanomedicine groups and diagnostic and food-safety labs studying…
Financial Health
StrongStrong · Growing, Hiring · 28% CAGR over 4y
Location
Agility Life Sciences Limited
Trajectory
3y · 2023–NowFinancial sub-scores
Computed from 3 filingsProvides pharmaceutical formulation development services for biotech and drug companies. Develops and optimises formulations for small molecules and peptides, including oral, ocular, intranasal and…
Serves innovator biopharma and pharmaceutical companies developing small-molecule and peptide drug candidates, especially teams preparing preclinical, GLP toxicology, clinical or commercial studies.
Financial Health
DistressedDistressed · 0% CAGR over 2y
Location
Peptimatrix Limited
Trajectory
2y · 2024–NowFinancial sub-scores
Computed from 2 filingsDevelops and supplies synthetic peptide-based hydrogel materials for 3D cell culture. Products provide defined, animal‑free matrices used by pharmaceutical and biomedical researchers for disease…
Serves researchers and laboratory teams in pharmaceutical, biotech and academic biomedical research, particularly those involved in 3D cell culture, disease modelling, drug discovery and preclinical…
Financial Health
StrongStrong · Growing, Hiring · 25% CAGR over 1y
Location
Inventa Therapeutics Limited
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsFinancial Health
WeakWeak · 0% CAGR over 4y
Location
4D Medicine Limited
Trajectory
2y · 2023–NowFinancial sub-scores
Computed from 2 filingsDevelops bioabsorbable biomaterials and implantable medical devices. Uses its patented 4Degra polymer resin to design and 3D print biodegradable surgical implants, including interference screws, for…
Targets medical device companies, healthcare sales-channel partners and investors serving surgical markets, with an emphasis on global bioabsorbable implant applications.
Financial Health
HealthyHealthy · Hiring · 33% CAGR over 1y
Location
Advanced Bioprocess Services Limited
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsDevelops and licenses biological process technologies based on expanded bed bioreactor systems. Provides process development for wastewater treatment, fermentation and biocatalysis, enabling…
Serves B2B customers in water and wastewater treatment, industrial biotechnology, fermentation, pharmaceuticals, fine chemicals and biofuels, including organisations seeking licensed or…
Financial Health
HealthyHealthy · Hiring · 20% CAGR over 4y
Location
LOCATE BIO LIMITED
Trajectory
5y · 2020–NowFinancial sub-scores
Computed from 5 filingsDevelops orthobiologic medical products for musculoskeletal repair, including bone graft substitutes, tissue scaffolds and drug‑delivery systems. Products and pipeline include materials for bone…
Sells to orthopaedic and spinal surgeons and healthcare providers using orthobiologics for musculoskeletal procedures. Targets clinical users and medical stakeholders in the USA and other…
Financial Health
StrongStrong · Hiring · 6% CAGR over 4y
Location
Provides contract research, development and manufacturing services for pharmaceutical companies, including drug product formulation, small‑molecule development, clinical trial support, first‑in‑human…
Serves B2B pharmaceutical and biotech companies developing small-molecule therapies, from early candidate selection and first-in-human studies through to commercial launch.
Location
Quotient Sciences
Provides contract research, development and manufacturing services for pharmaceutical companies, including drug product formulation, clinical trial supply, first-in-human and clinical pharmacology…
Serves pharmaceutical and biotech companies developing small-molecule therapies, from early-stage R&D teams planning first-in-human studies to drug sponsors needing clinical and commercial…
Location
ANH Consultancy Limited
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsFinancial Health
DistressedDistressed
Location
Biosenex Limited
Trajectory
5y · 2020–NowFinancial sub-scores
Computed from 5 filingsFinancial Health
DistressedDistressed
Location
PRETECA UK LTD
Trajectory
4y · 2022–NowFinancial sub-scores
Computed from 4 filingsFinancial Health
StableStable
Location
AMPharma Solutions Limited
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsFinancial Health
WeakWeak · 0% CAGR over 4y
Location
MURRAY BIOSCIENCES LTD
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsFinancial Health
DistressedDistressed · -68% CAGR over 4y
Location
Unlock all 35 leads
Showing 34 of 35 — +1 more with verified decision-maker contacts, live data, and CRM sync.
How Nottingham Biotech companies work and how to sell to them
What they do
Nottingham biotech firms usually monetise scientific work before there is a marketed therapy, diagnostic or tool. Revenue tends to come from fee-for-service laboratory projects, assay development, access to specialist platforms, biological materials, research-tool sales, grant-backed collaborations and licensing of intellectual property. Pricing is often project-scoped, per-sample, per-assay or based on retained scientific capacity, while more speculative programmes use upfront fees, milestones and royalties. The commercial product is rarely just software or a physical item; it is usually a mix of know-how, lab process, evidence generation and defensible scientific claims.
Who they sell to
Most customers sit in research, clinical development or specialist laboratory functions rather than broad corporate buying teams. Typical buyers include heads of R&D, translational medicine leads, laboratory operations managers, clinical scientists, principal investigators and, later in the process, procurement, legal and IP teams. Smaller service engagements can move through direct scientific conversations, especially where a buyer already understands the method. Platform access, co-development and licensing discussions take longer, with evidence review, material-transfer terms, confidentiality, quality documentation and budget ownership all affecting the path to signature.
What they buy
Spend tends to follow the laboratory workflow: lab information management, electronic notebooks, quality management, sample tracking, bioinformatics, data storage, security, equipment servicing and specialist consumables. Firms moving nearer to clinical work tend to need regulatory affairs support, clinical operations, pharmacovigilance advice, document control, validation services and audit preparation. Commercially, many also buy CRM, grant support, finance systems, patent and licensing advice, scientific recruitment, insurance and marketing aimed at technical audiences. Infrastructure suppliers may find openings around controlled storage, cold-chain logistics, clean-lab fit-out and outsourced analytical capacity.
Why and how to sell to them
Pain points cluster around proof, documentation and runway. Biotech buyers tend to evaluate vendors when a programme moves from discovery into validation, when a new collaboration creates reporting obligations, when quality requirements tighten, or when fresh funding allows a lab to replace improvised systems. Outbound works better when it is anchored in a specific workflow, such as reducing repeat assay failure, preserving audit trails for MHRA-facing work, improving sample traceability or making partner diligence easier. Generic productivity language is less persuasive than evidence from comparable regulated laboratory settings and a clear path from pilot to adoption.
How this list is built
Data sources
This list is built from UK Companies House filings, XBRL accounts data, and semantic analysis of each company's public website. Revenue and headcount figures come from the most recent filed accounts; where the company has not filed, values are estimated using a model trained on filed history and peer benchmarks and are labelled as estimates.
Classification
Rather than relying solely on SIC codes, Firmbase classifies each company semantically: the company's website is crawled, an AI model reads what the company actually sells, and the company is placed into the relevant industry and subsectors. SIC codes are used as one signal but not the only one. This means a company that registered under a generic SIC code but pivoted into (for example) fintech is correctly identified as fintech, not as its original SIC category.
Freshness
The underlying company data is refreshed from Companies House continuously; filings appear in the list within days of submission. The curated list ordering is regenerated when the underlying data moves meaningfully (company count changes by more than 5%, a new company enters the top-ranked segment, or the filed-revenue numbers for the top firms change). You can see the last-updated timestamp near the top of the page.
Also in Nottingham
Related directories
Frequently asked questions
How many biotech companies are there in Nottingham?
What counts as a biotech company in this list?
Which are the largest biotech companies in Nottingham?
What do biotech companies in Nottingham actually do?
How does Nottingham biotech compare internationally?
How is this list built and how fresh is the data?
How big are the typical biotech companies in Nottingham?
Are these mostly new or established biotech companies?
What SIC codes does this use?
What buying signals should I look for?
Push these 35 companies into your pipeline.
Find the right decision-makers, see verified company data, and export your list in seconds.